Skip to main content
xMedica

Search

43 studies match these filters. Showing 26–43 of 43 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT06527222A Study of Ranolazine in ALS

The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 6 sites in total · contact listed

RecruitingPhase 272target6 / 12025Jun 8, 2026
NCT06492616A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 567 sites in total · contact listed

RecruitingPhase 34,220target567 / 282024Sep 15, 2026
NCT06937177Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

This is a randomized, double-blind, placebo-controlled basket trial evaluating mifomelatide (TCMCB07) administered daily by subcutaneous (SC) injection in up to 120 patients. Patients will be enrolled into two cohorts 1) patients with newly diagnosed, advanced, unresectable colorectal cancer (CRC) o…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 26 sites in total · contact listed

RecruitingPhase 2120target26 / 22025Jul 15, 2026
NCT07064473EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 1,143 sites in total · contact listed

RecruitingPhase 311,800target1,143 / 512025Sep 16, 2026
NCT05485961Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase 2b is a dose-finding study for CSL300 vs placebo. Part 2: Phase 3 aims to assess the efficacy of CSL300 vs placebo on cardiovascular (CV) out…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 557 sites in total · contact listed

RecruitingPhase 2 / Phase 33,110target557 / 352022Aug 11, 2026
NCT07190300TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

The purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total · contact listed

RecruitingPhase 1 / Phase 2181target31 / 142026Jun 23, 2026
NCT04553770Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

This phase II trial investigates how well trastuzumab deruxtecan works alone or in combination with anastrozole in treating patients with HER2 low, hormone receptor positive breast cancer. Trastuzumab deruxtecan is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called derux…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 9 sites in total · contact listed

RecruitingPhase 288target9 / 12020Nov 10, 2025
NCT03723928S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as t…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 723 sites in total

RecruitingNot applicable739target723 / 32018Apr 2, 2026
NCT05827081Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 229 sites in total · contact listed

RecruitingPhase 31,400target229 / 162024Sep 18, 2026
NCT07225946A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of treatment until disease worsens as determined by scans or death due to any cause) when compared to treatment with docetaxe…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 152 sites in total

RecruitingPhase 3800target152 / 172025Aug 28, 2026
NCT06982521Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 (zovegalisib) + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 231 sites in total

RecruitingPhase 3540target231 / 242025Sep 3, 2026
NCT07453069Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle

The goal of this clinical trial is to evaluate FB301 during a mock frozen embryo transfer (FET) cycle in pre-menopausal women aged 18 to 40 years with a prior failed FET and a defined vaginal bacterial imbalance (dysbiosis). The main question it aims to answer is: • Does treatment with FB301 durin…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 4 sites in total · contact listed

RecruitingPhase 230target4 / 12026Sep 3, 2026
NCT04729114A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potential treatment for men with advanced prostate cancer. It is given by an injection into the muscle. Men with advanced prostate cancer can take part in this study. Their canc…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 25 sites in total

RecruitingPhase 1174target25 / 22021Feb 4, 2026
NCT06531824EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicines called angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). Pe…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 557 sites in total · contact listed

RecruitingPhase 311,000target557 / 202024Sep 17, 2026
NCT02402244Project: Every Child for Younger Patients With Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 279 sites in total · contact listed

Recruiting75,000target279 / 62015Aug 25, 2026
NCT06906562A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or has spread from where it first started to other places in the body…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 109 sites in total · contact listed

RecruitingPhase 240target109 / 12025Feb 17, 2026
NCT05334069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early…

Contact Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 745 sites in total · contact listed

Recruiting2,000target745 / 12022Sep 2, 2026
NCT03866382Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blo…

Contact Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 581 sites in total

RecruitingPhase 2314target581 / 22019Sep 16, 2026

Filters

Clear all filters